Ultragenyx Pharmaceutical | La Marge Brute Sur Les Ventes



Gross Profit On Sales Changement Date
Acadia Pharmaceuticals USD 237.8M 72.86M 2024-12
Agios Pharmaceuticals USD 7.64M 1.83M 2025-03
Alnylam Pharmaceuticals USD 523.15M 32.8M 2025-03
BioMarin Pharmaceutical USD 593.59M 17.59M 2025-03
Insmed USD 78.29M 6.04M 2024-12
Ionis Pharmaceuticals USD 130.15M 92.6M 2025-03
Kyowa Hakko Kirin JPY 80.14B 15.15B 2025-03
MacroGenics USD 13.86M 94.98M 2024-12
Moderna USD 17M 403M 2025-03
Neurocrine Biosciences USD 618.4M 4.3M 2024-12
PTC Therapeutics USD 196.89M 10.95M 2024-12
Regeneron Pharmaceuticals USD 2.56B 659.4M 2025-03
Sarepta Therapeutics USD 526.11M 150.63M 2024-12
Ultragenyx Pharmaceutical USD 147.98M 29.51M 2024-12
Vertex Pharmaceuticals USD 2.49B 109.3M 2024-12



Ultragenyx Pharmaceutical La Marge Brute Sur Les Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.